PDF herunterladen
Methods Inf Med 1993; 32(03): 237-240
DOI: 10.1055/s-0038-1634919
Original Article
Schattauer GmbH

Criteria for Screening Diabetes Mellitus Using Serum Fructosamine Level and Fasting Plasma Glucose Level

N. Kasezawa
1   Shizuoka Medical Center
1   Shizuoka Medical Center
,
H. Kiyose
2   Shin-Tokyo Hospital
1   Shizuoka Medical Center
,
K. Ito
3   Tokyo University School of Medicine
1   Shizuoka Medical Center
,
T. Iwatsuka
4   Aichi Prefectural Center for Health Care
1   Shizuoka Medical Center
,
H. Kawai
5   Kyoueiscimei Foundation of Health
1   Shizuoka Medical Center
,
Y. Goto
6   Tohoku Koseinenkin Hospital
1   Shizuoka Medical Center
,
K. Kondo
7   Midori Health Promotion Center
1   Shizuoka Medical Center
,
N. Sasamori
8   Makita General Hospital
1   Shizuoka Medical Center
,
K. Suzuki
1   Shizuoka Medical Center
1   Shizuoka Medical Center
,
T. Suzuki
9   Tokyo Metropolitan Police Hospital
1   Shizuoka Medical Center
,
G. Tanaka
10   Takatsu Central Hospital
1   Shizuoka Medical Center
,
M. Tamai
11   Sumitomo Seimei Multiphasic Health Testing System shin-Osaka
1   Shizuoka Medical Center
,
S. Yamazaki
12   Itoshima-gun Medical Association Hospital
1   Shizuoka Medical Center
,
T. Yoda
13   Okayama Red Cross Hospital
1   Shizuoka Medical Center
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
06. Februar 2018 (online)

    Lizenzen und Reprints

Abstract:

A screening method using serum fructosamine level and the fasting plasma glucose level was used for screening patients with diabetes mellitus. The criteria for positive tests recommended by the Japanese Society of Multiphasic Health Testing and Services were evaluated. It was found that levels for the serum fructosamine of 290 µmol/l or higher (or, for the fasting plasma glucose of 110 mg/dl or higher) agreed with the standard oral glucose tolerance test in identifying patients with diabetes mellitus in 96.7% of cases, and the serum fructosamine test was simpler and less expensive.

Key-Words

Screening - Diabetes Mellitus - Serum Fructosamine - Plasma Glucose
 

  • REFERENCES

  • 1 Kiyose H, Tanaka G. Glucose tolerance screening method using a combination of fasting plasma glucose and hemoglobin AIc . J Jpn Diabetes Soc 1987; 30: 325-31.
    PubMedSuche in Google Scholar
  • 2 Bunn H, Gabbay K, Gallop P. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978; 200: 21-7.
    CrossrefPubMedSuche in Google Scholar
  • 3 Baker J, O-Connor J, Metcalf P, Lawson M, Johnson R. Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. Br Med J 1983; 287: 863-7.
    CrossrefPubMedSuche in Google Scholar
  • 4 Baker J, Metcalf P, Scragg R, Johnson R. Fructosamine Test-Plus, a modified fructosamine assay evaluated. Clin Chem 1991; 37: 552-6.
    PubMedSuche in Google Scholar
  • 5 European Fructosamine Workshop, Vienna 1989. In: Kraupp O, Sinzinger H. eds. Vienna: Springer Verlag; 1990: 1-96.
  • 6 Egashira S, Yamazaki S. A study on the methodology of diabetes mellitus screening in half-day medical checkups. JMHTS 1989; 16: 24-31.
    CrossrefPubMedSuche in Google Scholar
  • 7 Hirano K, Suzuki A, Yamasawa I. Screening tests of cases high blood sugar in human dry dock. JMHTS 1990; 17: 49-57.
    CrossrefPubMedSuche in Google Scholar
  • 8 Kasezawa N, Suzuki K. The clinical and economical usefulness of determination of serum fructosamine by a new methodology and fasting plasma glucose as a screening test for diabetes mellitus. JMHTS 1991; 18: 290-1.
    CrossrefPubMedSuche in Google Scholar
  • 9 Kosaka K, Akanuma Y, Goto Y. A report of the committee for the diagnosis of diabetes mellitus. J Jpn Diab Soc 1982; 25: 859-86.
    PubMedSuche in Google Scholar